Abstract
References
Articles referenced by this article (52)
Title not supplied
2001
The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress.
Acta Histochem, (2):112-118 2008
MED: 18617226
Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules.
Ann Allergy Asthma Immunol, (6):670-674 2005
MED: 15984600
Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.
Clin Exp Allergy, (5):805-811 2008
MED: 18325031
Pharmacology of leukotriene receptor antagonists.
Am J Respir Crit Care Med, (6 Pt 2):S214-8; discussion S218-9, S247-8 1998
MED: 9647602
Title not supplied
Afr. J. Microbiol. Res., (1) 2012
Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action.
Gastroenterology, (5 Pt 1):1178-1186 1990
MED: 2157619
Title not supplied
Int. J. Pharm. Sci. Rev. Res., (3) 2011
Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats.
J Physiol Pharmacol, (3):455-467 2007
MED: 17928642
Show 10 more references (10 of 52)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1002/jbt.21979
Article citations
The renoprotective potential of montelukast: a scoping review.
Ann Med Surg (Lond), 86(6):3568-3576, 22 Apr 2024
Cited by: 0 articles | PMID: 38846849
Review
Evaluation of Effect of Montelukast in the Model of Streptozotocin Induced Diabetic Nephropathy in Rats.
Indian J Endocrinol Metab, 28(1):47-54, 01 Jan 2024
Cited by: 0 articles | PMID: 38533280 | PMCID: PMC10962779
Montelukast induces beneficial behavioral outcomes and reduces inflammation in male and female rats.
Front Immunol, 13:981440, 06 Sep 2022
Cited by: 5 articles | PMID: 36148246 | PMCID: PMC9487911
Leukotriene Receptor Antagonist, Montelukast Ameliorates L-NAME-Induced Pre-eclampsia in Rats through Suppressing the IL-6/Jak2/STAT3 Signaling Pathway.
Pharmaceuticals (Basel), 15(8):914, 24 Jul 2022
Cited by: 5 articles | PMID: 35893738 | PMCID: PMC9332684
Interference with megalin expression/endocytic function by montelukast mitigates gentamicin nephrotoxicity: Downregulation of ClC-5 expression.
Saudi Pharm J, 30(2):150-161, 04 Jan 2022
Cited by: 4 articles | PMID: 35528850 | PMCID: PMC9072701
Go to all (8) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Ellagic acid antiinflammatory and antiapoptotic potential mediate renoprotection in cisplatin nephrotoxic rats.
J Biochem Mol Toxicol, 28(10):472-479, 10 Jul 2014
Cited by: 16 articles | PMID: 25044399
Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney.
Ren Fail, 35(3):403-410, 24 Jan 2013
Cited by: 24 articles | PMID: 23342977
Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.
Naunyn Schmiedebergs Arch Pharmacol, 389(8):819-830, 23 May 2016
Cited by: 8 articles | PMID: 27215580
Minireview. The nephrotoxicity of cisplatin.
Life Sci, 32(7):685-690, 01 Feb 1983
Cited by: 120 articles | PMID: 6338333
Review